The Veterinary clinics of North America. Equine practice2023; S0749-0739(23)00067-6; doi: 10.1016/j.cveq.2023.10.001

Pyrogallol Toxicosis in Horses.

Abstract: Plants in the maple genus, Acer, and pistachio genus, Pistacia, have been reported to cause acute hemolysis in horses. The cause of hemolysis seems to be metabolism of gallic acids to the potent oxidant pyrogallol by enteric bacteria of the horse. Diagnosis is often tentative and circumstantial. Treatment is symptomatic and supportive and can include detoxification, fluid and electrolyte therapy, supplemental oxygen, and pain control. Corticosteroid and antioxidant therapies do not improve prognosis. Prognosis is guarded to poor but horses that survive 6 days postexposure are expected to recover.
Publication Date: 2023-11-01 PubMed ID: 37923643DOI: 10.1016/j.cveq.2023.10.001Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article
  • Review

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This study examines the damaging effects of pyrogallol, a substance found in certain plants including the maple and pistachio genus, on horses. It emphasizes that intake of these plants can cause acute hemolysis in horses and explains the possible treatments available.

Pyrogallol Toxicosis in Horses

The paper discusses findings about how pyrogallol toxicity adversely affects horses. It was found that:

  • Plants like those from the maple (Acer) and pistachio (Pistacia) genus are harmful to horses due to the presence of gallic acids, which can lead to pyrogallol toxicosis.
  • Horses’ gut bacteria metabolize these gallic acids into a potent oxidant, pyrogallol, which can cause acute hemolysis (rapid breakdown of red blood cells). This elucidates the possible link between gallic acid and the toxicity seen in horses.
  • The diagnosis of this condition is often circumstantial and tentative, suggesting that additional research is needed to establish definitive diagnostic procedures.

Treatments for Pyrogallol Toxicosis

The research paper further describes several treatment options for horses affected by pyrogallol, including:

  • Detoxification to eliminate the toxic pyrogallol from their system.
  • Fluid and electrolyte therapy to help replenish lost or depleted fluids and minerals.
  • Supplemental oxygen, potentially beneficial for horses experiencing respiratory distress due to hemolysis.
  • Pain management to reduce any discomfort the horse may be experiencing.

Interestingly, treatments such as corticosteroid and antioxidant therapies, typically used for anti-inflammatory and cell protection purposes, were found not to improve the prognosis for pyrogallol toxicosis.

Prognosis for Horses with Pyrogallol Toxicosis

The paper concludes with an observation about the prognosis for affected horses, stating that:

  • The prognosis for horses with pyrogallol toxicosis is generally guarded to poor, implying a high likelihood of a negative outcome despite treatment efforts.
  • However, horses that manage to survive for six days post exposure to pyrogallol have an expected higher chance of recovery. This is a significant finding and could serve as a benchmark for treating equine patients in the future.

Cite This Article

APA
Bischoff K. (2023). Pyrogallol Toxicosis in Horses. Vet Clin North Am Equine Pract, S0749-0739(23)00067-6. https://doi.org/10.1016/j.cveq.2023.10.001

Publication

ISSN: 1558-4224
NlmUniqueID: 8511904
Country: United States
Language: English
PII: S0749-0739(23)00067-6

Researcher Affiliations

Bischoff, Karyn
  • Department of Population Medicine and Diagnostic Sciences, Cornell University College of Veterinary Medicine, New York State Animal Health Diagnostic Center, PO Box 5786, Ithaca, NY 14853, USA. Electronic address: KLB72@cornell.edu.

Conflict of Interest Statement

Disclosure The author has nothing to disclose.

Citations

This article has been cited 0 times.